AD |
Alzheimer’s disease |
Akt |
RAC-alpha serine/threonine-protein kinase |
ALS |
Amyotrophic lateral sclerosis |
aPC |
Activated protein C |
ApoM |
Apolipoprotein M |
APP |
Amyloid precursor protein |
Aβ |
Amyloid-β-peptide |
BBB |
Blood brain barrier |
CBAs |
Conjugated bile acids |
CBF |
Cerebral blood flow |
CCL4 |
C-C motif chemokine 4-like |
CCL5 |
C-C motif chemokine 5-like |
CCO |
Cytochrome c oxidase |
CCR7 |
C-C chemokine receptor type 7 |
CD |
Cluster of differentiation molecule |
CDase |
Ceramidase |
c-fos |
Proto-oncogene c-Fos |
cIAP2 |
Cellular inhibitor of apoptosis 2 |
CNS |
Central nervous system |
COX-2 |
Cyclooxygenase-2 |
CXCL8 |
C-X-C motif chemokine 8, IL-8 |
CXCL10 |
C-X-C motif chemokine 10 |
DHHC5 |
Palmitoyltransferase DHHC5 |
DNA |
Desoxyribonucleic acid |
EAE |
Experimental autoimmune encephalomyelitis |
EC |
Extracellular |
ERK |
Extracellular-regulated kinase |
GBA |
Glucocerebrosidase |
GCS |
Glucosylceramide synthase |
Glc |
Glucose |
GlcCer |
Glucosylceramidase |
GRK2 |
G protein-coupled receptor kinase 2 |
Gαi/o
|
Inhibitory Gα subunit |
Gαq
|
q subtype of Gα proteins |
Gαs
|
Stimulatory Gα subunit |
G12/13
|
12/13 subtype of Gα proteins |
HD |
Huntigton’s disease |
HDAC1/2 |
Histone deacetylases 1/2 |
HDL |
High-density lipoprotein |
hTERT |
Human telomerase reverse transcriptase |
IC |
Intracellular |
ICAM1 |
Intracellular adhesion molecule 1 |
IFN-α |
Interferon α |
IL-1 |
Interleukin-1 |
IL-6 |
Interleukin-6 |
IL-17A |
Interleukin-17A |
IRF1 |
Interferon regulatory factor 1 |
IκB |
Inhibitor of nuclear factor κ-B kinase |
IκBα |
NF-κB inhibitor α |
LBD |
Lewy body disorders |
LDL |
Low-density lipoprotein |
LPP |
Lipid phosphate phosphohydrolase |
MCAO |
Middle cerebral artery occlusion |
MFSD2B |
Major facilitator superfamily domain-containing protein 2B |
MKRN1 |
Makorin ring finger protein 1 |
MMP-9 |
Matrix metalloproteinase-9 |
mRNA |
Messenger ribonucleic acid |
MS |
Multiple slerosis |
NF-κB |
Nuclear factor κ-light-chain-enhancer of activated B cells |
NMO |
Neuromyelitis optica |
NVU |
Neurovascular unit |
ORMDL3 |
ORM1-like protein 3 |
OXPHOS |
Oxidative phosphorylation |
PalCoA |
Palmitoyl-CoA |
PD |
Parkinson’s disease |
PE |
Phosphoethanolamine |
PGC1β |
PPARγ co-activator 1β |
PHB2 |
Prohibitin-2 |
PKC |
Protein kinase C |
PKCζ |
Atypical PKC subtype ζ |
PKCι |
Atypical PKC subtype ι |
PLPP3 |
Phospholipid phosphatase 3 |
PM |
Plasma membrane |
PPARγ |
Peroxisome proliferator activated receptor γ |
PTX3 |
Pentraxin-related protein 3 |
p21 |
Cyclin-dependent kinase inhibitor 1 |
RACK |
Receptor for activated C kinase proteins |
RhoA |
Transforming protein RhoA |
RING |
Really interesting new group |
RIP1 |
Receptor-interacting serine/threonine-protein kinase 1 |
rt-PA |
Recombinant-tissue plasminogen activator |
SAH |
Subarachnoid hemorrhage |
sER |
Smooth endoplasmic reticulum |
SGPL1 |
S1P lyase 1 |
SGPP1/2 |
Sphingosine 1-phosphate phosphohydrolase 1/2 |
SLE |
Systemic lupus erythematosus |
SMase |
Sphingomyelinase |
SMS |
Sphingomyelin synthase |
SphK1 |
Sphingosine kinase 1 |
SphK2 |
Sphingosine kinase 2 |
SPNS2 |
Spinster homolog 2 |
SPT |
Serine palmitoyltransferase |
STAT3 |
Signal transducer and activator of transcription 3 |
S1P |
Sphingosine 1-phosphate |
S1PR |
Sphingosine 1-phosphate receptor |
S1P1–5
|
S1PR subtype 1–5 |
TAB3 |
TGF-β-activated kinase 1 and MAP3K7-binding protein3 |
TFH
|
Follicular TH cell |
TGF-β |
Transforming-growth-factor-β |
TH-17 |
TH-17 type cell |
TNFRSF12A |
Tumor necrosis factor receptor superfamily member 12A |
TNF-α |
Tumor necrosis factor-α |
TRAF2 |
TNF-α receptor-associated factor 2 |
TRAF6 |
TNF-α receptor-associated factor 6 |
TREG
|
Regulatory T cell |
TUNEL |
Terminal deoxynucleotidyl transferase-mediated, uridine 5′triphosphate-biotin nick end-labeling |
UGT8A |
UDP galactosyltransferase 8A |
VEGFa |
Vascular endothelial growth factor A |
VLDL |
Very low-density lipoprotein |
WWP2 |
NEDD4-like E3 ubiquitin ligase WWP2 |